#pharmaindustry

GLP-1 Weight Loss Drugs Lift Pharma Profits, But Deloitte Warns of Bubble Risk
New pancreatic cancer drug shows major survival gains in Phase 3 study
Trump drug pricing deals seen as limited relief for most U.S. patients
AD
AD
AD
AD
AD
AD
AD
AD
AD